Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Passage Bio
Passage Bio
CEO Shakeups at BIO, Passage Bio and Palisade Bio
CEO Shakeups at BIO, Passage Bio and Palisade Bio
BioSpace
BIO
Passage Bio
Palisade Bio
Maze Therapeutics
Cerecin
Pharma CEOs
Flag link:
Passage Bio CEO Bruce Goldsmith Abruptly Steps Down
Passage Bio CEO Bruce Goldsmith Abruptly Steps Down
BioSpace
Passage Bio
Bruce Goldsmith
Pharma CEOs
layoffs
Flag link:
'Stay alive': Wave of layoffs crashes into biotech startup inferno
'Stay alive': Wave of layoffs crashes into biotech startup inferno
Fierce Biotech
biotech
layoffs
startups
Zosano Pharma
Ovid Therapeutics
Passage Bio
Athenex
Flag link:
Passage Bio to cut jobs in latest biotech restructuring
Passage Bio to cut jobs in latest biotech restructuring
BioPharma Dive
Passage Bio
restructuring
gene therapy
layoffs
Flag link:
A high-profile gene therapy biotech takes aim at Huntington's
A high-profile gene therapy biotech takes aim at Huntington's
BioPharma Dive
Passage Bio
gene therapy
Huntington's disease
Flag link:
Approved! FDA Grants IND Clearance to Three More Candidates Today
Approved! FDA Grants IND Clearance to Three More Candidates Today
BioSpace
FDA
IND clearance
COPD
Zofin
Organicell
COVID-19
Passage Bio
PBFT02
frontotemporal dementia
KemPharm
KP879
stimulant use disorder
Flag link:
FDA puts up a red light for Passage Bio’s first gene therapy program
FDA puts up a red light for Passage Bio’s first gene therapy program
Endpoints
Passage Bio
gene therapy
FDA
Flag link:
Covid-19 stalls biotech flotations
Covid-19 stalls biotech flotations
EP Vantage
COVID-19
IPOs
Revolution Medicines
Black Diamond Therapeutics
Passage Bio
Beam Therapeutics
Schrödinger
Flag link:
Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO
Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO
Endpoints
Passage Bio
IPOs
gene therapy
Flag link:
Gene therapy startup Passage Bio nabs Janssen neuro lead as CMO
Gene therapy startup Passage Bio nabs Janssen neuro lead as CMO
Fierce Biotech
gene therapy
Passage Bio
Janssen
Flag link:
Plotting clinical entry, James Wilson's gene therapy startup brings in billionaire for $110M Series B
Plotting clinical entry, James Wilson's gene therapy startup brings in billionaire for $110M Series B
Endpoints
gene therapy
Passage Bio
Access Biotechnology
Flag link:
More M&A Activity Expected Around AAV-Based Gene Therapies, Analyst Says
More M&A Activity Expected Around AAV-Based Gene Therapies, Analyst Says
BioSpace
gene therapy
M&A
Audentes Therapeutics
Regenxbio
Passage Bio
Flag link: